Arsenic in drinking water and risk of urinary tract cancer

A follow-up study from Northeastern Taiwan

Chi Ling Chen, Hung Yi Chiou, Ling I. Hsu, Yu Mei Hsueh, Meei Maan Wu, Yuan Hung Wang, Chien Jen Chen

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

The evidence linking arsenic in drinking water with increased urinary cancer risk comes from populations in relatively high exposure areas (>100 μg/L), whereas studies from lower exposure areas (100 μg/L), the relative risks (RR) were >5-fold, whereas the risk was elevated but not significant for low exposure (50 years (RR, 4.12; 95% CI, 1.48-11.5) had a significantly increased risk of urinary cancer. When restricted to urothelial carcinoma, all risk estimates including concentration and characteristics of well water consumption were higher.

Original languageEnglish
Pages (from-to)101-110
Number of pages10
JournalCancer Epidemiology Biomarkers and Prevention
Volume19
Issue number1
DOIs
Publication statusPublished - Jan 2010

Fingerprint

Urologic Neoplasms
Arsenic
Taiwan
Drinking Water
Drinking
Neoplasms
Carcinoma
Population

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Arsenic in drinking water and risk of urinary tract cancer : A follow-up study from Northeastern Taiwan. / Chen, Chi Ling; Chiou, Hung Yi; Hsu, Ling I.; Hsueh, Yu Mei; Wu, Meei Maan; Wang, Yuan Hung; Chen, Chien Jen.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 19, No. 1, 01.2010, p. 101-110.

Research output: Contribution to journalArticle

@article{33844921bf0d4ae98ae6fcb596aeeb6a,
title = "Arsenic in drinking water and risk of urinary tract cancer: A follow-up study from Northeastern Taiwan",
abstract = "The evidence linking arsenic in drinking water with increased urinary cancer risk comes from populations in relatively high exposure areas (>100 μg/L), whereas studies from lower exposure areas (100 μg/L), the relative risks (RR) were >5-fold, whereas the risk was elevated but not significant for low exposure (50 years (RR, 4.12; 95{\%} CI, 1.48-11.5) had a significantly increased risk of urinary cancer. When restricted to urothelial carcinoma, all risk estimates including concentration and characteristics of well water consumption were higher.",
author = "Chen, {Chi Ling} and Chiou, {Hung Yi} and Hsu, {Ling I.} and Hsueh, {Yu Mei} and Wu, {Meei Maan} and Wang, {Yuan Hung} and Chen, {Chien Jen}",
year = "2010",
month = "1",
doi = "10.1158/1055-9965.EPI-09-0333",
language = "English",
volume = "19",
pages = "101--110",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Arsenic in drinking water and risk of urinary tract cancer

T2 - A follow-up study from Northeastern Taiwan

AU - Chen, Chi Ling

AU - Chiou, Hung Yi

AU - Hsu, Ling I.

AU - Hsueh, Yu Mei

AU - Wu, Meei Maan

AU - Wang, Yuan Hung

AU - Chen, Chien Jen

PY - 2010/1

Y1 - 2010/1

N2 - The evidence linking arsenic in drinking water with increased urinary cancer risk comes from populations in relatively high exposure areas (>100 μg/L), whereas studies from lower exposure areas (100 μg/L), the relative risks (RR) were >5-fold, whereas the risk was elevated but not significant for low exposure (50 years (RR, 4.12; 95% CI, 1.48-11.5) had a significantly increased risk of urinary cancer. When restricted to urothelial carcinoma, all risk estimates including concentration and characteristics of well water consumption were higher.

AB - The evidence linking arsenic in drinking water with increased urinary cancer risk comes from populations in relatively high exposure areas (>100 μg/L), whereas studies from lower exposure areas (100 μg/L), the relative risks (RR) were >5-fold, whereas the risk was elevated but not significant for low exposure (50 years (RR, 4.12; 95% CI, 1.48-11.5) had a significantly increased risk of urinary cancer. When restricted to urothelial carcinoma, all risk estimates including concentration and characteristics of well water consumption were higher.

UR - http://www.scopus.com/inward/record.url?scp=74549153186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74549153186&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-09-0333

DO - 10.1158/1055-9965.EPI-09-0333

M3 - Article

VL - 19

SP - 101

EP - 110

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 1

ER -